DNOW
DNOW Inc. · Industrials · Industrial Distribution
Last
$13.93
+$0.06 (+0.40%) 4:00 PM ET
After hours $14.17 +$0.24 (+1.76%) 5:41 PM ET
Prev close $13.87
Open $13.78
Day high $14.19
Day low $13.77
Volume 2,741,065
Avg vol 2,949,411
Mkt cap
$2.53B
P/E ratio
-11.60
FY Revenue
$3.40B
EPS
-1.20
Gross Margin
15.63%
Sector
Industrials
AI report sections
DNOW
DNOW Inc.
DNOW Inc. shows upward price momentum with the latest close above short- and medium-term moving averages and near the upper half of its 52-week range, supported by bullish breakout technical patterns and elevated RSI. Fundamentally, the company combines modest revenue growth, double-digit net income and EPS growth, positive free cash flow, and a debt-free balance sheet, while facing thin operating and net margins and a decline in operating cash flow growth. Valuation multiples, including a P/E above 30 and EV/EBITDA above 15, appear relatively elevated versus the company’s low single-digit revenue growth and mid-single-digit margins, with short interest and neutral legal-focused news adding a measured risk backdrop.
AI summarized at 1:38 AM ET, 2026-02-03
AI summary scores
INTRADAY: 68 SWING: 72 LONG: 63
Volume vs average
Intraday (cumulative)
+53% (Above avg)
Vol/Avg: 1.53×
RSI
62.48 (Strong)
Strong (60–70)
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.02 Signal: 0.02
Short-Term
+0.08 (Strong)
MACD: 0.03 Signal: -0.05
Long-Term
+0.02 (Strong)
MACD: 0.11 Signal: 0.08
Intraday trend score 84.32

Latest news

DNOW 12 articles Positive: 0 Neutral: 0 Negative: 12
Negative GlobeNewswire Inc. • Rosen Law Firm
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOX

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.

NNOX ADMA DNOW securities class action false statements manufacturing operations cash burn lead plaintiff deadline
Sentiment note

Company is subject to ongoing securities investigation by Rosen Law Firm with shareholders encouraged to contact regarding potential losses, suggesting alleged securities violations or shareholder harm.

Negative GlobeNewswire Inc. • Rosen Law Firm
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

Rosen Law Firm is pursuing securities class action lawsuits against ADMA Biologics, Nano-X Imaging, and DNOW Inc. on behalf of investors. The ADMA case alleges undisclosed related party transactions, channel stuffing, and inadequate internal controls during the August 2024 to March 2026 period, with an August 10, 2026 deadline for lead plaintiff claims.

ADMA NNOX DNOW securities class action investor fraud related party transactions channel stuffing internal controls
Sentiment note

Under investigation by Rosen Law Firm for potential securities claims on behalf of shareholders, suggesting alleged investor losses.

Negative GlobeNewswire Inc. • The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to fall 19.1% on February 20, 2026. Investors who purchased DNOW securities may be entitled to compensation through a class action lawsuit.

DNOW securities class action misleading business information disappointing financial results stock decline investor losses shareholder litigation
Sentiment note

Company reported disappointing fourth-quarter 2025 financial results including significant losses and missed Wall Street expectations, resulting in a 19.1% stock decline and triggering a securities class action investigation for allegedly issuing materially misleading business information.

Negative GlobeNewswire Inc. • Rosen Law Firm
VERI DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - VERI

Rosen Law Firm is notifying investors about ongoing securities class action lawsuits against Veritone Inc., Badger Meter Inc., and DNOW Inc. Veritone investors who purchased securities between October 14, 2025 and April 14, 2026 are encouraged to join the class action by the July 20, 2026 deadline. The lawsuit alleges Veritone made false statements regarding revenue recording, misclassified costs, and maintained deficient internal controls, leading to required financial statement restatements.

VERI BMI DNOW securities class action financial restatement accounting fraud investor losses lead plaintiff deadline
Sentiment note

Company is subject to potential securities claims being investigated by Rosen Law Firm on behalf of shareholders, suggesting alleged violations and investor harm.

Negative GlobeNewswire Inc. • Rosen Law Firm
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Badger Meter, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BMI

Rosen Law Firm is soliciting investors who purchased securities of Badger Meter, Veritone, and DNOW during specified class periods to join securities class action lawsuits. The firm alleges that Badger Meter made false statements about financial results by pulling forward customer orders to conceal weakening demand. Lead plaintiff deadlines and contact information are provided for interested investors.

BMI VERI DNOW securities class action investor losses false statements revenue recognition lead plaintiff deadline
Sentiment note

Company is the subject of an ongoing securities claims investigation by Rosen Law Firm on behalf of shareholders, suggesting potential securities violations or shareholder losses.

Negative GlobeNewswire Inc. • The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to plummet 19.1% on February 20, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

DNOW securities fraud class action lawsuit misleading business information Q4 2025 earnings stock decline investor losses
Sentiment note

Company reported disappointing fourth-quarter 2025 financial results with significant losses and missed Wall Street expectations, resulting in a 19.1% stock price decline and triggering a securities investigation for allegedly issuing materially misleading business information.

Negative GlobeNewswire Inc. • The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE: DNOW) for allegedly issuing materially misleading business information. The company reported disappointing fourth-quarter 2025 financial results with significant losses and missed Wall Street expectations, causing the stock to fall 19.1% on February 20, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

DNOW securities fraud class action lawsuit misleading financial information stock decline investor losses fourth-quarter earnings miss
Sentiment note

The company is under investigation for issuing materially misleading business information, reported disappointing Q4 2025 results with significant losses, missed Wall Street expectations, and experienced a sharp 19.1% stock price decline on the news announcement.

Negative GlobeNewswire Inc. • Rosen Law Firm
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against multiple companies. Disc Medicine (IRON) received an FDA Complete Response Letter on its bitopertin program, causing a 22% stock price decline on February 13, 2026. The firm is also pursuing class action lawsuits against DNOW Inc. and Badger Meter, Inc. on behalf of affected shareholders.

IRON DNOW BMI securities class action FDA Complete Response Letter investor losses stock price decline shareholder litigation
Sentiment note

Company is subject to securities class action investigation by Rosen Law Firm for potential securities claims, indicating alleged misconduct or misleading disclosures to investors.

Negative GlobeNewswire Inc. • Rosen Law Firm
UP Fintech Investor News: If You Have Suffered Losses in UP Fintech Holding Limited (NASDAQ: TIGR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of UP Fintech Holding Limited following China's announced crackdown on cross-border securities trading. The regulatory action caused UP Fintech's stock to plummet 25.3% on May 22, 2026. The firm is also investigating similar claims against DNOW Inc. and Badger Meter, Inc.

TIGR DNOW BMI securities class action China regulatory crackdown cross-border investment investor losses stock decline
Sentiment note

Subject of securities claims investigation by Rosen Law Firm, indicating potential investor losses and legal exposure.

Negative GlobeNewswire Inc. • The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against DNOW Inc. (NYSE: DNOW) following the company's disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing a 19.1% stock decline on February 20, 2026. The firm is also investigating claims against UP Fintech Holding Limited (NASDAQ: TIGR) and GeneDx Holdings Corp. Investors who suffered losses are encouraged to join prospective class actions.

WGS WGSWW DNOW TIGR securities class action investor losses misleading business information disappointing financial results
Sentiment note

Company reported disappointing fourth-quarter 2025 financial results with significant losses and missed Wall Street expectations, resulting in a 19.1% stock price decline and triggering securities fraud investigation.

Negative GlobeNewswire Inc. • The Rosen Law Firm
UP Fintech Investor News: If You Have Suffered Losses in UP Fintech Holding Limited (NASDAQ: TIGR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against UP Fintech Holding Limited (TIGR) following China's announcement of a crackdown on cross-border securities trading. UP Fintech's shares fell 25.3% on May 22, 2026, after Reuters reported that Chinese regulators would penalize brokers for illegally moving money to foreign markets. The firm is also investigating claims against DNOW Inc. and GeneDx Holdings Corp.

TIGR DNOW WGS WGSWW securities class action China crackdown cross-border investment investor losses
Sentiment note

Company is subject to a securities class action investigation by The Rosen Law Firm, indicating potential shareholder losses and legal claims.

Negative GlobeNewswire Inc. • The Rosen Law Firm
DNOW Investor News: If You Have Suffered Losses in DNOW Inc. (NYSE: DNOW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against DNOW Inc. after the company reported disappointing fourth-quarter 2025 financial results that missed Wall Street expectations, causing the stock to plummet 19.1% on February 20, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

DNOW securities fraud class action lawsuit misleading business information Q4 2025 earnings stock decline investor losses
Sentiment note

Company reported disappointing fourth-quarter 2025 financial results with significant losses that missed Wall Street expectations, triggering a 19.1% stock price decline and prompting a securities investigation for allegedly issuing materially misleading business information.

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal